ES2537539T3 - Composición oftálmica - Google Patents

Composición oftálmica Download PDF

Info

Publication number
ES2537539T3
ES2537539T3 ES10165945.6T ES10165945T ES2537539T3 ES 2537539 T3 ES2537539 T3 ES 2537539T3 ES 10165945 T ES10165945 T ES 10165945T ES 2537539 T3 ES2537539 T3 ES 2537539T3
Authority
ES
Spain
Prior art keywords
ophthalmic composition
hyaluronic acid
composition
corneal
osmoprotection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10165945.6T
Other languages
English (en)
Inventor
Lucia Gelsomino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALFA INTES IND TERAPEUTICA SPLENDORE Srl
ALFA INTES INDUSTRIA TERAPEUTICA SPLENDORE Srl
Original Assignee
ALFA INTES IND TERAPEUTICA SPLENDORE Srl
ALFA INTES INDUSTRIA TERAPEUTICA SPLENDORE Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALFA INTES IND TERAPEUTICA SPLENDORE Srl, ALFA INTES INDUSTRIA TERAPEUTICA SPLENDORE Srl filed Critical ALFA INTES IND TERAPEUTICA SPLENDORE Srl
Application granted granted Critical
Publication of ES2537539T3 publication Critical patent/ES2537539T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición oftálmica, en particular para la estabilización de la película corneal, la cicatrización corneal, la restauración del contenido salino de la lágrima, y la osmoprotección, caracterizada por comprender una disolución acuosa que contiene cobalamina, ácido hialurónico y/o una o más sales de ácido hialurónico, y taurina, y una o más sustancias estabilizadoras del pH para mantener la composición a un pH comprendido entre aproximadamente 6,0 y aproximadamente 7,5.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES10165945.6T 2009-06-15 2010-06-15 Composición oftálmica Active ES2537539T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000102U ITRM20090102U1 (it) 2009-06-15 2009-06-15 Ialuvit preparato per la stabilizzazione del film lacrimale, la cicatrizzazione corneale e il ripristino del contenuto salino della lacrima e osmoprotezione.
ITRM20090102U 2009-06-15

Publications (1)

Publication Number Publication Date
ES2537539T3 true ES2537539T3 (es) 2015-06-09

Family

ID=42782620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10165945.6T Active ES2537539T3 (es) 2009-06-15 2010-06-15 Composición oftálmica

Country Status (3)

Country Link
EP (1) EP2263648B1 (es)
ES (1) ES2537539T3 (es)
IT (1) ITRM20090102U1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX346362B (es) 2009-11-10 2017-03-15 Allegro Pharmaceuticals Inc * Composiciones y metodos para inhibir la adhesion celular o dirigir agentes de diagnostico o terapeuticos a sitios de enlace rgd.
US11673914B2 (en) 2009-11-10 2023-06-13 Allegro Pharmaceuticals, LLC Peptide therapies for reduction of macular thickening
IT1406954B1 (it) * 2011-02-22 2014-03-14 O V I Optical Venture Italy Srl Lenti a contatto morbide ad elevato confort, ottenute mediante trattamento con soluzioni a base di aloe vera ed acido ialuronico
AT511164A1 (de) 2011-03-03 2012-09-15 Croma Pharma Gmbh Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
ITTO20111135A1 (it) * 2011-12-12 2013-06-13 Alfa Intes Ind Terapeutica Sp Lendore S R L Ialuvit preparato per la stabilizzazione del film lacrimale, la cicatrizzazione corneale e il ripristino del contenuto salino della lacrima e osmoprotezione
CA3015452C (en) * 2016-05-10 2023-08-22 Colgate-Palmolive Company Taurine and aloe synergistic anti-irritant compositions and methods
JP7133942B2 (ja) * 2018-02-27 2022-09-09 ロート製薬株式会社 眼科組成物
WO2020219475A1 (en) * 2019-04-22 2020-10-29 Allegro Ophthalmics, Llc Compositions and methods useable for treatment of dry eye
RU2706703C1 (ru) * 2019-08-19 2019-11-20 Общество с ограниченной ответственностью "ПРОФИТ ФАРМ" Раствор увлажняющий офтальмологический
WO2024084435A2 (en) * 2022-10-21 2024-04-25 Montefarmaco Otc S.P.A. Viscous ophthalmic liquid composition comprising natural gums and extracts
US20240156857A1 (en) * 2022-11-11 2024-05-16 Bausch + Lomb Ireland Limited Hydration formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2849378B1 (fr) * 2003-04-30 2008-08-22 Jean Noel Thorel Utilisation d'une base nutritive complexe en tant que medicament ophtalmologique, ou pour la mise en oeuvre de pieces de type lentilles de contact
EP2002841A4 (en) * 2006-03-23 2009-04-15 Senju Pharma Co OPHTHALMIC COMPOSITION WITH XANTHANGUMMI AND GLUCOSE
WO2008001872A1 (fr) * 2006-06-28 2008-01-03 Rohto Pharmaceutical Co., Ltd. Composition ophthalmique contenant de l'acide alginique ou un sel de celui-ci

Also Published As

Publication number Publication date
ITRM20090102U1 (it) 2010-12-16
EP2263648B1 (en) 2015-04-08
EP2263648A1 (en) 2010-12-22

Similar Documents

Publication Publication Date Title
ES2537539T3 (es) Composición oftálmica
GT200600420A (es) Sales novedosas de lisina de derivados de acido 4-((fenoxialquil)tio)-fenoxiacetico
ES2546198T3 (es) Tratamiento contra la glomerulonefritis
AR084285A1 (es) Composiciones inmunogenicas
CO6290622A2 (es) Composiciones de activo antitranspirante con un cromatograma sec que presenta una elevada intensidad de pico 4 sec para reducir la transpiración
BR112015007571A2 (pt) dispositivo para fornecimento de medicamento
ES2563777T3 (es) Compuestos de nitrona para tratar la pérdida auditiva sensorineural
AR081983A1 (es) Articulo de dosis unitaria soluble que comprende un polimero cationico
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
ES2509966T1 (es) Composiciones que tienen concentraciones incrementadas de carboximetilcelulosa
AR096773A1 (es) Formulación líquida estable
AR093460A1 (es) Medios de cultivo celular
NZ608202A (en) Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
ES2543957T3 (es) Nueva composición farmacéutica para el tratamiento de infecciones fúngicas
ES2666720T3 (es) Composición para prevenir o tratar el cáncer de cuello uterino con un potenciador de la inmunidad contra el virus de papiloma humano
PE20141539A1 (es) Una nueva composicion terapeutica que contiene apomorfina como principio activo
ES2629407T3 (es) Soluciones acuosas que contienen un agente complejante en alta concentración
ES2531516T3 (es) Uso de escina
CR20140053A (es) Formulaciones de ácido desoxicólico y sales del mismo
CL2011000806A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
AR084537A1 (es) Solucion acuosa de ambroxol
ES2508165T3 (es) Lactoferrina y sustancia blanca
CO6382164A2 (es) Solucion acuosa para la preservacion de tejidos y organos
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
NI201000173A (es) Uso de dronedarona o una sal aceptable farmacéuticamente de ésta, para la preparación de un medicamento para regular el nivel de potasio en la sangre.